11-687941-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_021008.4(DEAF1):c.634G>A(p.Gly212Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G212C) has been classified as Pathogenic.
Frequency
Consequence
NM_021008.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal dominant 24Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- intellectual disability-epilepsy-extrapyramidal syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- complex neurodevelopmental disorderInheritance: SD Classification: STRONG Submitted by: Illumina
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 24 Pathogenic:4
This missense variant has been observed once in our laboratory de novo in a 15-year-old female with intellectual disability, developmental regression, autism spectrum disorder, seizure disorder, mild dysmorphisms, large hands. -
- -
- -
- -
not provided Pathogenic:3
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 212 of the DEAF1 protein (p.Gly212Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with DEAF1-related conditions (PMID: 28940898, 30923367). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 375554). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DEAF1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects DEAF1 function (PMID: 28940898, 30923367). For these reasons, this variant has been classified as Pathogenic. -
DEAF1: PS2, PM1, PM2, PM5, PP3, PS3:Supporting -
Published functional studies demonstrate that this missense variant, which is located in the SAND domain, causes impaired transcriptional regulation (Chen et al., 2017; Nabais Sa et al., 2019); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22941188, 28940898, 30923367, 30109124, 33994118) -
Neurodevelopmental delay Pathogenic:1
- -
Intellectual disability, autosomal dominant 24;C4310683:Intellectual disability-epilepsy-extrapyramidal syndrome Other:1
Variant interpreted as Pathogenic and reported on 03-05-2018 by Lab or GTR ID 26957. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR ) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator John Constantino MD PhD from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at